Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.57% | 190.45 | 1.2% | $558.00m | |
| GILD | Gilead Sciences, Inc. | -0.35% | 70.67 | 0.9% | $494.00m | |
| BIIB | Biogen Inc. | -1.47% | 314.39 | 1.3% | $441.96m | |
| CELG | Celgene Corporation | -0.88% | 69.62 | 1.2% | $414.72m | |
| ILMN | Illumina, Inc. | -1.14% | 307.63 | 3.5% | $393.75m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -1.56% | 336.77 | 2.6% | $277.39m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -3.79% | 163.85 | 1.9% | $261.05m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -1.86% | 116.32 | 2.0% | $195.38m | |
| A | Agilent Technologies, Inc. | -1.21% | 63.56 | 1.5% | $166.10m | |
| EXAS | Exact Sciences Corporation | -1.79% | 68.17 | 25.3% | $146.98m | |
| LGND | Ligand Pharmaceuticals Incorporated | -0.42% | 147.80 | 23.3% | $143.00m | |
| SRPT | Sarepta Therapeutics, Inc. | -4.98% | 110.95 | 16.4% | $126.92m | |
| ECYT | Endocyte, Inc. | -0.09% | 23.56 | 2.0% | $120.16m | |
| INCY | Incyte Corporation | -0.21% | 63.60 | 2.5% | $112.16m | |
| NKTR | Nektar Therapeutics | 1.66% | 37.97 | 5.6% | $107.61m |
Company Profile
Aevi Genomic Medicine, Inc. is a clinical stage biopharmaceutical company, which engages in finding treatments for rare and orphan diseases. Its research and development efforts leverage an internal genomics platform and an ongoing collaboration with the Center for Applied Genomics (CAG) at The Children's Hospital of Philadelphia (CHOP). The company was founded on January 27, 2000 and is headquartered in Wayne, PA.